ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Diagnostic Tests"

  • Abstract Number: 158 • 2014 ACR/ARHP Annual Meeting

    Performance of Joint Ultrasonography in the Diagnosis of Suspected Acute Crystal Arthritis : Results of a Prospective Study of 112 Patients

    Pascal Zufferey1, Isabelle Fabreguet1, Roxana Valcov1, Alexandre Dumusc1 and Alexander K. So Sr.2, 1DAL, RHU/CHUV, Lausanne, Switzerland, 2Dal/Rhu, CHUV, Lausanne, Switzerland

    Background/Purpose The gold standard for diagnosing gout and CCP arthritis is the identification of monosodium urate (MSU) crystals in joint fluid. Ultrasound (US) features of…
  • Abstract Number: 2209 • 2014 ACR/ARHP Annual Meeting

    Novel Biomarkers of Extracellular Matrix Remodeling in Inflammatory Bowel Disease: Different Patterns of Gut Injury in UC and CD

    Joachim Høg Mortensen1, Line Elberg Godskesen2, Michael Dam Jensen2, Lone Gabriels Klinge2, Jens Kjeldsen2, Aleksander Krag2, Morten Karsdal3 and Anne C. Bay-Jensen4, 1Cartilage Biomarkers and Research, Nordic Bioscience, Købehavn, Denmark, 2Odense University Hospital, Odense, Denmark, 3Research & Development, Nordic Bioscience, Biomarkers and Research, Herlev, Denmark, 4Cartilage Biomarkers and Research, Nordic Bioscience, Herlev, Denmark

     Background/Purpose: About 10 % of patients with IBD have symptoms that match both Crohn's disease (CD) and ulcerative colitis (UC), termed inflammatory bowel disease unclassified…
  • Abstract Number: 148 • 2014 ACR/ARHP Annual Meeting

    Value of Ultrasonography Parotid Glands in Patients with Suspected Primary Sjögren’s Syndrome

    Marina Oliver1, Lida Santiago2, Paula Gonzalez1, Diego Vila1, Sebastian fernandez Nacul1, Santiago Scarafia3, Marta Mamani4 and Anastasia Secco3, 1Rheumatology, Rivadavia Hospital, Buenos Aires, Argentina, 2hospital rivadavia, CABA, Argentina, 3Rheumatology, Hospital Bernardino Rivadavia, Buenos Aires, Argentina, 4Hospital Rivadavia, Capital Federal, Argentina

    Background/Purpose Primary Sjogren’s syndrome (pSS) is an autoimmune disorder characterised by chronic lymphocytic infiltration of exocrine tissues. Currently new non-invasive techniques are being continuously introduced…
  • Abstract Number: 2057 • 2014 ACR/ARHP Annual Meeting

    Electrophysiological Evaluation of Autonomic Nervous System and Cutaneous Silent Period in Patients with Fibromyalgia Syndrome

    Isil Ustun1, Ilker Yagci2, Gulseren Akyuz3 and Feyza Unlu,Ozkan4, 1Physical Medicine and Rehabilitation, Bagcilar Training Hospital, Istanbul, Turkey, 2Marmara Universitesi T?p Fakultesi, Istanbul, Turkey, 3Physical Medicine and Rehabilitation, Marmara University School of Medicine, Istanbul, Turkey, 4Fatih Sultan Mehmet Training Hospital, Istanbul, Turkey

    Background/Purpose This study was designed to investigate the autonomic nervous system (ANS) and spinal inhibitory circuits in FMS by electrophysiological studies and compare the results…
  • Abstract Number: 1995 • 2014 ACR/ARHP Annual Meeting

    Design and Implementation of a Clinical Teaching Tool for Approach to Children with Suspected New Rheumatologic Diagnosis

    Kristen Hayward1 and Jennifer Hrachovec2, 1Pediatric Rheumatology, Seattle Children's Hospital, Seattle, WA, 2Clincal Effectiveness, Seattle Children's Hospital, Seattle, WA

    Background/Purpose Approximately 1 in 1000 children suffer from a rheumatologic disorder. Despite the relative frequency of these conditions, there is a shortage of pediatric rheumatologists…
  • Abstract Number: 1867 • 2014 ACR/ARHP Annual Meeting

    Mandibular Movement in Healthy Individuals from 4-17 Years of Age

    Peter Stoustrup1, Kasper Dahl Kristensen2,3, Annelise Küseler4, Thomas Klit Pedersen5,6 and Troels Herlin7, 1Section of Orthodontics, University of Aarhus, Aarhus C, Denmark, 2Section of Orthodontics, University of Aarhus, Denmark, 8000 Aarhus, Denmark, 3Specialist Oral Health Center for Western Norway, Rogaland Stavanger, Norway, 4Section of Orthodontics, Aarhus University, Aarhus, Denmark, 5Section or Orthodontics, Aarhus University, Aarhus, Denmark, 6Department of Oral and Maxillofacial Surgery, Aarhus University Hospital, Aarhus, Denmark, 7Pediatric Rheumatology Clinic, Department of Pediatrics, Aarhus University Hospital, Aarhus, Denmark

    Background/Purpose: Assessment of mandibular movement capacity is an important part of the clinical orofacial examination of patients with juvenile idiopathic arthritis (JIA). The aim of…
  • Abstract Number: 1756 • 2014 ACR/ARHP Annual Meeting

    Molecular Diagnosis Reveals a Surprising Prevalence of Limited Gpa Among Patients with Orbital Inflammatory Diseases

    James T. Rosenbaum1, Dongseok Choi2, Christine Harrington3, Patrick Stauffer4, David Wilson5, Seema Gupta4, Roger Dailey4, John Ng4, Eric Steele4, Patrick Yeatts6, Peter Dolman7, Valerie White7, Gerald Harris8, Craig Czyz9, Jill Foster9, Deepak Edward10, Hind Alkatan10, Bobby Korn11, Don Kikkawa12, Dinesh Selva13, Sander Dubovy14, Chris Alabiad15, David Tse15, Michael Kazim16, Payal Patel16 and Stephen R. Planck17, 1OHSU, Portland, OR, 2Casey Eye Institute, Oregon Health and Science University, Portland, OR, 3Integrated Genomics, Oregon Health & Science University, Portland, OR, 4Oregon Health & Science University, Portland, OR, 5Casey Eye Institute/Ophthalmology, Oregon Health & Science University, Portland, OR, 6Ophthalmology, Wake Forest University, Winston-Salem, NC, 7University of British Columbia, Vancouver, BC, Canada, 8Medical College of Wisconsin, Milwaukee, WI, 9Ohio State Univeristy, Columbus, OH, 10King Khaled Eye Hospital, Riyadh, Saudi Arabia, 11University of California, San Diego, San Diego, CA, 12Ophthalmology, University of California, San Diego, San Diego, CA, 13Royal Adelaide Hospital, Adelaide, Australia, 14University of Miami, Miami, FL, 15Ophthalmology, University of Miami, Miami, FL, 16Columbia University, New York City, NY, 17Casey Eye Inst/Ophthalmology, Oregon Health & Science University, Portland, OR

    Background/Purpose: Gene expression profiling provides diagnostic and therapeutic information in several malignancies, but its role in evaluating inflammatory disease is relatively untested. We hypothesized that…
  • Abstract Number: 1762 • 2014 ACR/ARHP Annual Meeting

    The Muscle Biopsy Is a Useful and Noninvasive Procedure in Diagnosing Systemic Vasculitis Affecting Small-to-Medium-Sized Vessels: A Prospective Evaluation

    Takahiro Nunokawa1, Takayasu Kise1, Naoto Yokogawa2, Kota Shimada1 and Shoji Sugii2, 1Department of Rheumatic diseases, Tokyo Metropolitan Tama Medical Center, Tokyo, Japan, 2Department of Rheumatic Diseases, Tokyo Metropolitan Tama Medical Center, Tokyo, Japan

    Background/Purpose: Histopathological confirmation is required for the diagnosis of systemic vasculitis. However, patients suspected of vasculitis often only have lesions with a low diagnostic yield…
  • Abstract Number: 1138 • 2013 ACR/ARHP Annual Meeting

    Tuberculin Skin Test and Booster Phenomenon In a Rheumatoid Arthritis Population. Differences Between Early and Established Disease

    Lorena Perez-Barbosa1, David Vega-Morales2, Janett Carmen Luzmilla Riega-Torres1, Octavio Ilizaliturri-Guerra1 and Mario Alberto Garza-Elizondo1, 1Early Arthritis Clinic, Rheumatology Service, Hospital Universitario, Monterrey, Mexico, 2Rheumatology, Hospital Universitario UANL, Monterrey, Mexico

    Background/Purpose: Tuberculosis (TB) remains a major global health problem.   Chronic inflammation in Rheumatoid Arthritis (RA) and the use of immunosuppressive drugs, increase the risk of…
  • Abstract Number: 671 • 2013 ACR/ARHP Annual Meeting

    Autoantibody Diversity In Scleroderma Patients With Antinucleolar Antibodies and Negative For Three Major Disease-Specific Markers

    Sarada Nandiwada1, Troy Jaskowski2, Maureen D. Mayes3, Minoru Satoh4 and Anne E. Tebo1, 1Pathology, University of Utah, Salt Lake City, UT, 2ARUP Laboratories, Salt Lake City, UT, 3University of Texas Health Science Center at Houston, Houston, TX, 4Medicine, University of Florida, Gainesville, FL

    Background/Purpose: Antinuclear antibodies (ANA) in a nucleolar pattern (antinucleolar antibodies, ANoA) by indirect immunofluorescence technique correlate with several autoantibody specificities and clinical manifestations in scleroderma…
  • Abstract Number: 639 • 2013 ACR/ARHP Annual Meeting

    Examination Of The Cytokine Profile Of The Cerebrospinal Fluid In Neuropsychiatric Systemic Lupus Erythematosus

    Kunihiro Ichinose1, Takeshi Ushigusa2, Yoshikazu Nakashima3, Takahisa Suzuki3, Yoshiro Horai4, Shin-ya Kawashiri2, Naoki Iwamoto2, Mami Tamai3, Kazuhiko Arima4, Hideki Nakamura2, Tomoki Origuchi5 and Atsushi Kawakami4, 1Department of Immunology and Rheumatology, Unit of Translational Medicine, Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan, 2Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan, 3Unit of Translational Medicine, Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan, 4Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan, 5Department of Health Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan

    Examination of the cytokine profile of the cerebrospinal fluid in neuropsychiatric systemic lupus erythematosusBackground/Purpose: Neuropsychiatric systemic lupus erythematosus (NPSLE) is a serious complication in systemic…
  • Abstract Number: 520 • 2013 ACR/ARHP Annual Meeting

    Chronic Obstructive Pulmonary Disease Is Very Common in Primary Sjögren’s Syndrome

    Anna M. Nilsson1, Elke Theander2, Roger Hesselstrand3, Eeva Piitulainen4, Sandra Diaz5, Olle Ekberg5, Per Wollmer6 and Thomas Mandl7, 1Dept of Rheumatology, Skane University Hospital Malmo, Lund University, Malmo, Sweden, 2Section of Rheumatology, Department of Clinical Sciences, Malmö, Lund University, Malmö, Sweden, 3Rheumatology, Lund University, Lund, Sweden, 4Dept of Lung medicine, Lund University & Skåne University Hospital, Malmö, Sweden, 5Dept of Radiology, Skåne University Hospital Malmo, Lund University, Malmö, Sweden, 6Dept of Clinical Physiology, Skane University Hospital Malmo, Lund University, Malmö, Sweden, 7Dept of Rheumatology, Skåne University Hospital Malmo, Lund University, Sweden, Malmö, Sweden

    Background/Purpose: To study the prevalence of chronic obstructive pulmonary disease (COPD) in patients with primary Sjögren's syndrome (pSS) and its association with respiratory symptoms, pulmonary…
  • Abstract Number: 183 • 2013 ACR/ARHP Annual Meeting

    The Performance Of a Point Of Care Test For Detection Of Anti-Mutated Citrullinated Vimentin and Rheumatoid Factor In Early Rheumatoid Arthritis

    Preeda Rojanasantikul1, Prapa Pattrapornpisut2, Kulvara Anuruckparadorn3 and Wanruchada Katchamart1, 1Division of Rheumatology, Department of Internal Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand, 2Department of Internal Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand, 3Department of Transfusion Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand

    Background/Purpose: Besides rheumatoid factor (RF), anti-cyclic citrullinated peptide antibody (ACPA), a newer serologic marker, was added to the new American College of Rheumatology (ACR)/European League…
  • Abstract Number: 2553 • 2013 ACR/ARHP Annual Meeting

    The Clinical Value Of Testing For Aphl, a New ELISA Kit With a Unique Phospholipid Mixture In Patients With Systemic Lupus Erythematosus (SLE)

    Savino Sciascia1, Giovanni Sanna2, Veronica Murru3, Munther A. Khamashta4 and Maria Laura Bertolaccini3, 1Department of Rare, Immunologic, Hematologic and Immunohematologic Diseases, Centro di Immunopatologia e Documentazione su Malattie rare, Torino, Italy, 2Louise Coote Lupus Unit, St. Thomas' Hospital, London, United Kingdom, 3Lupus Research Unit, The Rayne Institute, Kings College London School of Medicine, London, United Kingdom, 4Lupus Research Unit, The Rayne Institute, St Thomas Hospital, Kings College London School of Medicine, London, United Kingdom

    Background/Purpose:  Antibodies directed to APhL (a mixture of phospholipids) have been reported to predict APS more reliably than aCL tests. We designed this study to…
  • Abstract Number: 2525 • 2013 ACR/ARHP Annual Meeting

    An Assay Panel Combining Cell Bound Complement Activation Products With Autoantibodies To Extractable Nuclear Antigens and Mutated Citrullinated Vimentin Helps With The Differential Diagnosis Of Systemic Lupus Erythematosus

    Chaim Putterman1, Richard Furie2, R. Ramsey-Goldman3, Anca Askanase4, Jill P. Buyon5, Kenneth C. Kalunian6, W. Winn Chatham7, Elena M. Massarotti8, Emily C. Somers9, Irene Blanco10, Puja Chitkara11, Nicole Jordan12, Kyriakos A. Kirou13, Arthur Weinstein14, Susan Manzi15, Joseph M. Ahearn16, Claudia Ibarra17, Derren Barken18 and Thierry Dervieux19, 1Division of Rheumatology, Albert Einstein College of Medicine, Bronx, NY, 2North Shore-LIJ Health System, Lake Success, NY, 3Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, 4NYU School of Medicine, New York, NY, 5Medicine, Division of Rheumatology, NYU School of Medicine, New York, NY, 6UCSD School of Medicine, La Jolla, CA, 7University of Alabama at Birmingham, Birmingham, AL, 8Rheumatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 9IntMed, Environmental Health, and OB/GYN, University of Michigan, Ann Arbor, MI, 10Rheumatology, Albert Einstein College of Medicine, Bronx, NY, 11Rheumatology, SDAMC, San Diego, CA, 12Department of Rheumatology, Albert Einstein College of Medicine, Bronx, NY, 13Hospital for Special Surgery, New York, NY, 14Washington Hospital Center, Washington, DC, 15Division of Rheumatology, University of Pittsburgh School of Medicine, Pittsburgh, PA, 16Lupus Center of Excellence, West Penn Allegheny Health System, Pittsburgh, PA, 17Clinical Laboratory, Exagen Diagnostics, Vista, CA, 18Exagen Diagnostics, Vista, CA, 19Research and Development, Exagen Diagnostics, Vista, CA

    Background/Purpose: We previously established the value of cell-bound complement activation products (CBCAPS) in the diagnosis of systemic lupus erythematosus (SLE) (CAPITAL study). The purpose of…
  • « Previous Page
  • 1
  • …
  • 5
  • 6
  • 7
  • 8
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

ACR Abstract Embargo Policy

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. Academic institutions, private organizations and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part a scientific presentation or presentation of additional new information that will be available at the time of the meeting) is under embargo until Saturday, November 11, 2023.

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying financial and other sponsors about this policy. If you have questions about the abstract embargo policy, please contact the public relations department at [email protected].

Copyright Policy

View ACR Policies.

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology